Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions frequently praise the AI-powered platform’s ability to identify dual-purpose aging targets, with phrases like 'game-changing' and 'promising targets' reflecting excitement and perceived significance. The tone is enthusiastic, and examples include references to the cover feature, innovative methods, and the potential for translating findings into therapies.
Most discussions praise the research, highlighting its significance and potential in aging and drug discovery, indicating strong support.
The discussions show high interest, with mentions of the paper being a cover article, promising targets, and technological advances, attracting attention from the community.
The posts include specific praises, references to figures and methods, and future implications, reflecting deep engagement.
Many comments suggest the publication could influence drug discovery strategies and aging research, indicating a high potential impact.
Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine https://t.co/yLJUsnV7dN Frank Pun @amoskalev @jpsenescence @biogerontology & colleagues Finding best candidates... Targets a/w Hallmarks of Aging
Our paper on #AgingTargets just made Top 100 in @AgingJrnl by my favorite score @altmetric . https://t.co/3kRDhUsN1T https://t.co/3gfq3QyFx3
Just learned that we made the Cover of @AgingJrnl - a comprehensive list of promising targets structured by hallmarks of aging may be very useful for drug discovery. Biotechs can follow on the footsteps of the pioneers like @CambrianBio or @rejuveron_life https://t.co/3gfq3QzdmB
Following FightAging for years. Nice to see our work covered here. https://t.co/UF0HlqAjpd And yes, @bioagelabs is also a very cool company with a cool pipeline. They too are taking some of the targets in the paper in clinical trials. https://t.co/3gfq3QyFx3
NEW Video
PandaOmics。AIを使った老化の分子機序とターゲット解析。どこまでvalidationされていくか。老化＝ばらつき、でもあるので、分子機序を解析しながら、老化のbackgroudの設定や、老化の定義の設定が必要だろう いずれにしても面白い動き https://t.co/O8YR2wdasZ
Psychological factors such as loneliness and unhappiness contribute up to 1.65 years to biological age, highlighting their role alongside physical health in the aging process. The study uses deep learning to measure…
This study explores aging biology and identifies potential targets for drug discovery using the AI-powered PandaOmics platform, focusing on the hallmarks of aging such as inflammation and extracellular matrix stiffness…
RT @InSilicoMeds: NEW Video
RT @AgingJrnl: #PaperoftheDay: "Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powe…
RT @InSilicoMeds: NEW Video
RT @InSilicoMeds: NEW Video
RT @InSilicoMeds: NEW Video
NEW Video
@olexandr @regardthefrost Yes @olexandr , but you need to have a credible business model to get through clinical trials. I hope my TNIK program will show people how it is done. Check this out: https://t.co/NsKcde5Ejm
@ragheeb40 @LaurieGreen36 https://t.co/3gfq3QzdmB
RT @agingdoc1: Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery eng…
https://t.co/D3sJbMe3PH
RT @biogerontology: @VpRazvan Most of the time, you do not need to choose https://t.co/NsKcde6c8U
@VpRazvan Most of the time, you do not need to choose https://t.co/NsKcde6c8U
RT @longescience: The LSF is happy to see the ‘Hallmarks of aging targets predicted by AI’, coauthored by @biogerontology, making it to the…
RT @HayanoMotoshi: PandaOmics。AIを使った老化の分子機序とターゲット解析。どこまでvalidationされていくか。老化＝ばらつき、でもあるので、分子機序を解析しながら、老化のbackgroudの設定や、老化の定義の設定が必要だろう いずれにしても…
RT @HayanoMotoshi: PandaOmics。AIを使った老化の分子機序とターゲット解析。どこまでvalidationされていくか。老化＝ばらつき、でもあるので、分子機序を解析しながら、老化のbackgroudの設定や、老化の定義の設定が必要だろう いずれにしても…
RT @HayanoMotoshi: PandaOmics。AIを使った老化の分子機序とターゲット解析。どこまでvalidationされていくか。老化＝ばらつき、でもあるので、分子機序を解析しながら、老化のbackgroudの設定や、老化の定義の設定が必要だろう いずれにしても…
RT @HayanoMotoshi: PandaOmics。AIを使った老化の分子機序とターゲット解析。どこまでvalidationされていくか。老化＝ばらつき、でもあるので、分子機序を解析しながら、老化のbackgroudの設定や、老化の定義の設定が必要だろう いずれにしても…
PandaOmics。AIを使った老化の分子機序とターゲット解析。どこまでvalidationされていくか。老化＝ばらつき、でもあるので、分子機序を解析しながら、老化のbackgroudの設定や、老化の定義の設定が必要だろう いずれにしても面白い動き https://t.co/O8YR2wdasZ
RT @biogerontology: @LammingLab @JamesPeyer @mkaeberlein @NirBarzilaiMD Certainly a disease IHMO. They can call it anything as long as we c…
@LammingLab @JamesPeyer @mkaeberlein @NirBarzilaiMD Certainly a disease IHMO. They can call it anything as long as we can develop the interventions faster. Unfortunately, in the current paradigm we will always need to go dual-purpose. Otherwise, pharma will not take the programs forward https://t.co/3gfq3QzdmB
@AgingJrnl video
#SoundCloud summary of #research chosen as the cover paper for Volume 14, Issue 6: "Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine." https://t.co/o5E2MwVQyh #openaccess #aging #artificialintelligence
RT @Deep_Longevity: One step closer to an anti-aging silver bullet https://t.co/YmwytCR115
RT @AgingJrnl: #PaperoftheDay: "Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powe…
#PaperoftheDay: "Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine" https://t.co/DPcmgwx4k0 #aging #AI #drugdiscovery #medicine #pandaomics @InSilicoMeds
#AgingShort video on a #researchpaper selected as the cover for Volume 14, Issue 6: An #artificialintelligence-powered discovery engine was used to generate a list of dual-purpose (#age-associated & #aging-based disease) targets. Paper: https://t.co/yEQT7mdklG #openaccess https://t.co/27XCQuy6JE
RT @AgingJrnl: #PaperoftheDay: "Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powe…
RT @AgingJrnl: #PaperoftheDay: "Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powe…
RT @AgingJrnl: #PaperoftheDay: "Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powe…
#PaperoftheDay: "Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine" https://t.co/DPcmgwx4k0 #aging #AI #drugdiscovery #medicine #pandaomics @InSilicoMeds
#SoundCloud summary of #research chosen as the cover paper for Volume 14, Issue 6: "Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine." https://t.co/o5E2MxdrWR #openaccess #aging #artificialintelligence
RT @AgingJrnl: Watch: #AgingShort video on a #researchpaper selected as the cover for Volume 14, Issue 6: An #artificialintelligence-powere…
RT @AgingJrnl: Watch: #AgingShort video on a #researchpaper selected as the cover for Volume 14, Issue 6: An #artificialintelligence-powere…
RT @AgingJrnl: Watch: #AgingShort video on a #researchpaper selected as the cover for Volume 14, Issue 6: An #artificialintelligence-powere…
Watch: #AgingShort video on a #researchpaper selected as the cover for Volume 14, Issue 6: An #artificialintelligence-powered discovery engine was used to generate a list of dual-purpose (#age-associated & #aging-based disease) targets. Read: https://t.co/yEQT7mdklG #longevity https://t.co/jtuXh4NYlf
RT @Deep_Longevity: One step closer to an anti-aging silver bullet https://t.co/YmwytCR115
One step closer to an anti-aging silver bullet https://t.co/YmwytCR115
Data-driven, comprehensive analysis with our benchmarked methods and AIs :) Here, for dual-goal targets https://t.co/l5ntezGm0g
RT @biogerontology: Following FightAging for years. Nice to see our work covered here. https://t.co/UF0HlqAjpd And yes, @bioagelabs is also…
RT @biogerontology: Following FightAging for years. Nice to see our work covered here. https://t.co/UF0HlqAjpd And yes, @bioagelabs is also…
RT @biogerontology: Following FightAging for years. Nice to see our work covered here. https://t.co/UF0HlqAjpd And yes, @bioagelabs is also…
Following FightAging for years. Nice to see our work covered here. https://t.co/UF0HlqAjpd And yes, @bioagelabs is also a very cool company with a cool pipeline. They too are taking some of the targets in the paper in clinical trials. https://t.co/3gfq3QyFx3
Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine. https://t.co/iyPhF0rudJ
RT @longescience: The LSF is happy to see the ‘Hallmarks of aging targets predicted by AI’, coauthored by @biogerontology, making it to the…
RT @biogerontology: Just learned that we made the Cover of @AgingJrnl - a comprehensive list of promising targets structured by hallmarks o…
RT @biogerontology: Our paper on #AgingTargets just made Top 100 in @AgingJrnl by my favorite score @altmetric . https://t.co/3kRDhUsN1T…
RT @biogerontology: Our paper on #AgingTargets just made Top 100 in @AgingJrnl by my favorite score @altmetric . https://t.co/3kRDhUsN1T…
RT @biogerontology: Our paper on #AgingTargets just made Top 100 in @AgingJrnl by my favorite score @altmetric . https://t.co/3kRDhUsN1T…
RT @biogerontology: Our paper on #AgingTargets just made Top 100 in @AgingJrnl by my favorite score @altmetric . https://t.co/3kRDhUsN1T…
Aging Targets found by AI https://t.co/4RmlOThTYZ
https://t.co/PO5FHHKuNj
#AgingShort video on a #researchpaper selected as the cover for Volume 14, Issue 6: An #artificialintelligence-powered discovery engine was used to generate a list of dual-purpose (#age-associated & #aging-based disease) targets. Paper: https://t.co/yEQT7mdklG #openaccess https://t.co/Onqjca0L7W
Longevity pharmacology: Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine https://t.co/c98dZzRI33 #science #biology #longevity #pharmacology #hallmarks #disease
RT @biogerontology: Our paper on #AgingTargets just made Top 100 in @AgingJrnl by my favorite score @altmetric . https://t.co/3kRDhUsN1T…
RT @biogerontology: Our paper on #AgingTargets just made Top 100 in @AgingJrnl by my favorite score @altmetric . https://t.co/3kRDhUsN1T…
Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine - https://t.co/shnlvuJ6bB
RT @biogerontology: Our paper on #AgingTargets just made Top 100 in @AgingJrnl by my favorite score @altmetric . https://t.co/3kRDhUsN1T…
The LSF is happy to see the ‘Hallmarks of aging targets predicted by AI’, coauthored by @biogerontology, making it to the cover of @AgingJrnl. This work delivers findings useful to formulate future drug discovery strategies. #drugresearch https://t.co/wgTfasuUi8
RT @biogerontology: Our paper on #AgingTargets just made Top 100 in @AgingJrnl by my favorite score @altmetric . https://t.co/3kRDhUsN1T…
Our paper on #AgingTargets just made Top 100 in @AgingJrnl by my favorite score @altmetric . https://t.co/3kRDhUsN1T https://t.co/3gfq3QyFx3
RT @biogerontology: #longevity #agingtargets https://t.co/3gfq3QyFx3 https://t.co/btOJ6EyVoA
#longevity #agingtargets https://t.co/3gfq3QyFx3 https://t.co/btOJ6EyVoA
@MLevitt_NP2013 #longevity #agingtargets https://t.co/3gfq3QyFx3
RT @biogerontology: Just learned that we made the Cover of @AgingJrnl - a comprehensive list of promising targets structured by hallmarks o…
RT @biogerontology: Just learned that we made the Cover of @AgingJrnl - a comprehensive list of promising targets structured by hallmarks o…
RT @biogerontology: Just learned that we made the Cover of @AgingJrnl - a comprehensive list of promising targets structured by hallmarks o…
Just learned that we made the Cover of @AgingJrnl - a comprehensive list of promising targets structured by hallmarks of aging may be very useful for drug discovery. Biotechs can follow on the footsteps of the pioneers like @CambrianBio or @rejuveron_life https://t.co/3gfq3QzdmB
Check out this hallmark of #aging paper by the @InsilicoMed team through the use of #pandaOmics https://t.co/NGH51V3ZST #targetdiscovery #aiinhealthcare
RT @agingdoc1: Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery eng…
RT @AgingJrnl: "Hence, identifying potential targets that are implicated in multiple age-associated diseases, and also play a role in the b…
RT @AgingJrnl: "Hence, identifying potential targets that are implicated in multiple age-associated diseases, and also play a role in the b…
RT @AgingJrnl: "Hence, identifying potential targets that are implicated in multiple age-associated diseases, and also play a role in the b…
"Hence, identifying potential targets that are implicated in multiple age-associated diseases, and also play a role in the basic biology of aging, may have substantial benefits." Read Aging's latest cover paper: https://t.co/DPcmgwx4k0 #AI #ArtificialIntelligence #aging #medEd https://t.co/izlMjfaZ2c
Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine https://t.co/Npkp5n9K0K
RT @AgingJrnl: #SoundCloud summary of #research chosen as the cover paper for Volume 14, Issue 6: "Hallmarks of aging-based dual-purpose di…
#SoundCloud summary of #research chosen as the cover paper for Volume 14, Issue 6: "Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine." https://t.co/o5E2MxdrWR #openaccess #aging #artificialintelligence
RT @AgingJrnl: The cover of Aging's latest issue features Figure 3, "Targets associated with hallmarks of aging," from Pun et al. Read the…
RT @AgingJrnl: The cover of Aging's latest issue features Figure 3, "Targets associated with hallmarks of aging," from Pun et al. Read the…
RT @AgingJrnl: The cover of Aging's latest issue features Figure 3, "Targets associated with hallmarks of aging," from Pun et al. Read the…
The cover of Aging's latest issue features Figure 3, "Targets associated with hallmarks of aging," from Pun et al. Read the cover paper: https://t.co/DPcmgwx4k0 https://t.co/IHsKFmb2ZL
RT @AgingJrnl: Aging's #PaperoftheDay is the cover paper from the latest issue, entitled, "Hallmarks of aging-based dual-purpose disease an…
Aging's #PaperoftheDay is the cover paper from the latest issue, entitled, "Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine." https://t.co/DPcmgwx4k0 #aging #AI #drugdiscovery #medicine #pandaomics
RT @AgingJrnl: #AgingShort video on a #researchpaper selected as the cover for Volume 14, Issue 6: An #artificialintelligence-powered disco…
#AgingShort video on a #researchpaper selected as the cover for Volume 14, Issue 6: An #artificialintelligence-powered discovery engine was used to generate a list of dual-purpose (#age-associated & #aging-based disease) targets. Paper: https://t.co/yEQT7mdklG #openaccess https://t.co/NNlh1cRHjG
RT @agingdoc1: Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery eng…
"Study reveals both high confidence and novel targets associated with multiple hallmarks of #aging and demonstrates application of the #PandaOmics platform to target discovery across multiple disease areas." Congratulations to @AlexZhavoronkov team! https://t.co/l1bO68jZMK
RT @agingdoc1: Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery eng…
Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine | Aging https://t.co/X49GxcYL0t
https://t.co/v6MyOmubiB
RT @elidourado: Using machine learning to discover drug targets implicated both in aging and age-related diseases. Promising. If we develo…
Using machine learning to discover drug targets implicated both in aging and age-related diseases. Promising. If we develop drugs and get them approved for specific diseases, they could become available for off-label use for aging generally. https://t.co/1cXun9JAPb
RT @agingdoc1: Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery eng…
RT @agingdoc1: Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery eng…
RT @agingdoc1: Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery eng…
RT @nikmarino9: Impressive paper by @biogerontology and team https://t.co/oqMP1XLZFS
RT @agingdoc1: Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery eng…
Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine https://t.co/oujRmZ9UBq
Ranking is powerful. There are many hidden gems in this article by @InSilicoMeds. https://t.co/131uKVQ23K I can't deny I'm surprised by the KOL and Financial Scores (although I suppose commissions/VCs work as a filter for quality might is a cool idea). Also, cool graphics! https://t.co/LO3ErK7dXN
Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine https://t.co/rKV0FYjR8H
AI-based target discovery for aging-related diseases ☺️ fantastic news and congrats to the great authors lineup
RT @agingdoc1: Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery eng…
RT @agingdoc1: Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery eng…
Impressive paper by @biogerontology and team https://t.co/oqMP1XLZFS
RT @agingdoc1: Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery eng…
RT @agingdoc1: Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery eng…
Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine https://t.co/yLJUsnV7dN Frank Pun @amoskalev @jpsenescence @biogerontology & colleagues Finding best candidates... Targets a/w Hallmarks of Aging
AGING-US.COM. Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmic... Aging | doi:10.18632/aging.203960. Frank ...
https://doi.org/10.18632/aging.203960 · https://www.prnewswire.com ... Tags: aging research and drug discoverybiomarkers for agingbiomedical ...
In a separate paper, published in Aging, Insilico scientists ... 2022;doi:10.18632/aging.203960. Ren F, et al. Nat Biotechnol. 2024 ...
... age-associated targets predicted using PandaOmics AI-powered discovery engine. Aging. doi.org/10.18632/aging.203960. [3] Ren, F., et al ...
... age-associated targets predicted using PandaOmics AI-powered discovery engine. Aging. doi.org/10.18632/aging.203960. [3] Ren, F., et al ...
Aging. doi.org/10.18632/aging.203960 [3] Ren, F., et al. (2024) Un inhibidor de molécula pequeña TNIK dirigido a la fibrosis en modelos ...
Aging. doi.org/10.18632/aging.203960 [3] Ren, F., et al. (2024) Ein TNIK-Kleinmolekül-Inhibitor zielt auf Fibrose in präklinischen und ...
Aging. doi.org/10.18632/aging.203960 [3] Ren, F., et al. (2024) Um inibidor de molécula pequena TNIK visa fibrose em modelos pré-clínicos e ...
Aging. doi.org/10.18632/aging.203960 [3] Ren, F., et al. (2024) Un inhibiteur de TNIK à petite molécule cible la fibrose dans des modèles ...
... age-associated targets predicted using PandaOmics AI-powered discovery engine. Aging. doi.org/10.18632/aging.203960. [3] Ren, F., et al ...
... age-associated targets predicted using PandaOmics AI-powered discovery engine. Aging, 14(6), 2475–2506. https://doi.org/10.18632/aging.203960 ...
... age-associated targets predicted using PandaOmics AI-powered discovery engine, Aging, March 2022, https://doi.org/10.18632/aging.203960. Alex ...
... aging and disease, will present at The Fourth Summit ... doi.org/10.18632/aging.203960. Source: https://insilico.com ...
... age-associated targets predicted using PandaOmics AI-powered discovery engine. Aging （2022）https://doi.org/10.18632/aging.203960. 平台声明.
A
AZ
IM
MH
S
RF
HA
LG
KP
S
AL
R
DU
K
M正
ささ
H濱
RF
AU
CM
CB
CV
HA
PA
RV
LG
FG
D
TJ
EI
OU
M
A
SP
JM
NJ
HM
RS
LG
MO
KG
TF
T
P
SE
G
A
QL
AN
JF
IJ
O
OH
MC
GL
AE
DK
LM
ED
RN
OM
F
MB
AN
OL
RA
DB
A
LS
NM
JP
CC